Sinil Pharmaceutical is a finished-dose manufacturer based in South Korea. It appears in 17 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), ARCSA (EC) and ANPP (DZ).
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 13 | None |
| ARCSA (EC) | 3 | None |
| ANPP (DZ) | 1 | None |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Sinil Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free